Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combining dosiomics and machine learning methods for predicting severe cardiac diseases in childhood cancer survivors: the French Childhood Cancer Survivor Study.
Bentriou M, Letort V, Chounta S, Fresneau B, Do D, Haddy N, Diallo I, Journy N, Zidane M, Charrier T, Aba N, Ducos C, Zossou VS, de Vathaire F, Allodji RS, Lemler S. Bentriou M, et al. Front Oncol. 2024 Dec 2;14:1241221. doi: 10.3389/fonc.2024.1241221. eCollection 2024. Front Oncol. 2024. PMID: 39687880 Free PMC article.
Dosiomics-Based Prediction of Radiation-Induced Valvulopathy after Childhood Cancer.
Chounta S, Allodji R, Vakalopoulou M, Bentriou M, Do DT, De Vathaire F, Diallo I, Fresneau B, Charrier T, Zossou V, Christodoulidis S, Lemler S, Letort Le Chevalier V. Chounta S, et al. Among authors: bentriou m. Cancers (Basel). 2023 Jun 8;15(12):3107. doi: 10.3390/cancers15123107. Cancers (Basel). 2023. PMID: 37370717 Free PMC article.
The risk of valvular heart disease in the French Childhood Cancer Survivors' Study: Contribution of dose-volume histogram parameters.
Chounta S, Lemler S, Haddy N, Fresneau B, Mansouri I, Bentriou M, Demoor-Goldschmidt C, Diallo I, Souchard V, Do TD, Veres C, Surun A, Doz F, Llanas D, Vu-Bezin G, Rubino C, de Vathaire F, Letort V, Allodji RS. Chounta S, et al. Among authors: bentriou m. Radiother Oncol. 2023 Mar;180:109479. doi: 10.1016/j.radonc.2023.109479. Epub 2023 Jan 16. Radiother Oncol. 2023. PMID: 36657724
Inferring the initiation and development of myeloproliferative neoplasms.
Hermange G, Rakotonirainy A, Bentriou M, Tisserand A, El-Khoury M, Girodon F, Marzac C, Vainchenker W, Plo I, Cournède PH. Hermange G, et al. Among authors: bentriou m. Proc Natl Acad Sci U S A. 2022 Sep 13;119(37):e2120374119. doi: 10.1073/pnas.2120374119. Epub 2022 Sep 9. Proc Natl Acad Sci U S A. 2022. PMID: 36083966 Free PMC article.
Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets.
Tronik-Le Roux D, Sautreuil M, Bentriou M, Vérine J, Palma MB, Daouya M, Bouhidel F, Lemler S, LeMaoult J, Desgrandchamps F, Cournède PH, Carosella ED. Tronik-Le Roux D, et al. Among authors: bentriou m. Cancer Immunol Immunother. 2020 Jul;69(7):1237-1252. doi: 10.1007/s00262-020-02530-x. Epub 2020 Mar 12. Cancer Immunol Immunother. 2020. PMID: 32166404 Free PMC article.